SLNO (STOCKS)
Soleno Therapeutics, Inc. Common Stock
$52.650000
+0.020000 (+0.04%)
Prev close: $52.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Anish Bhatnagar
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,717.51M
- Employees
- 133
- P/E (TTM)
- 134.64
- P/B (TTM)
- 6.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $190.41M |
| Benefits Costs and Expenses | $169.52M |
| Cost Of Revenue | $2.70M |
| Costs And Expenses | $180.99M |
| Gross Profit | $187.71M |
| Nonoperating Income/Loss | $11.48M |
| Operating Expenses | $180.99M |
| Selling, General, and Administrative Expenses | $132.13M |
| Depreciation and Amortization | $2.02M |
| Research and Development | $40.63M |
| Other Operating Expenses | $6.22M |
| Operating Income/Loss | $9.41M |
| Income/Loss From Continuing Operations After Tax | $20.89M |
| Income/Loss From Continuing Operations Before Tax | $20.89M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | $20.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $20.89M |
| Net Income/Loss Available To Common Stockholders, Basic | $20.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $415.00K |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | -$415.00K |
| Basic Earnings Per Share | $0.40 |
| Diluted Earnings Per Share | $0.39 |
| Basic Average Shares | 50,817,586 |
| Diluted Average Shares | 52,384,886 |
| Assets | $563.83M |
| Current Assets | $355.81M |
| Inventory | $15.02M |
| Other Current Assets | $340.79M |
| Noncurrent Assets | $208.02M |
| Fixed Assets | $185.00K |
| Intangible Assets | $4.86M |
| Other Non-current Assets | $202.97M |
| Liabilities | $113.72M |
| Current Liabilities | $61.36M |
| Accounts Payable | $12.44M |
| Wages | $9.68M |
| Other Current Liabilities | $39.25M |
| Noncurrent Liabilities | $52.35M |
| Equity | $450.12M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $450.12M |
| Liabilities And Equity | $563.83M |
| Net Cash Flow From Operating Activities | $46.80M |
| Net Cash Flow From Operating Activities, Continuing | $46.80M |
| Net Cash Flow From Investing Activities | -$201.78M |
| Net Cash Flow From Investing Activities, Continuing | -$201.78M |
| Net Cash Flow From Financing Activities | $137.16M |
| Net Cash Flow From Financing Activities, Continuing | $137.16M |
| Net Cash Flow | -$17.82M |
| Net Cash Flow, Continuing | -$17.82M |
| Comprehensive Income/Loss | $20.94M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $20.94M |
| Other Comprehensive Income/Loss | $54.00K |